Proline oxidase functions as a mitochondrial tumor suppressor in human cancers.
Proline oxidase functions as a mitochondrial tumor suppressor in human cancers.
复制标题
DOI:
10.1158/0008-5472.can-09-1223
复制
发表时间:
2009-08-15
期刊:
影响因子:
11.2
通讯作者:
Phang JM
中科院分区:
文献类型:
--
作者:
Liu Y;Borchert GL;Donald SP;Diwan BA;Anver M;Phang JM
Tumor metabolism and bioenergetics have become important topics for cancer research and are promising targets for anticancer therapy. Although glucose serves as the main source of energy, proline, an alternative substrate, is important, especially during nutrient stress. Proline oxidase (POX), catalyzing the first step in proline catabolism, is induced by p53 and can regulate cell survival as well as mediate programmed cell death. In a mouse xenograft tumor model, we found that POX greatly reduced tumor formation by causing G2 cell cycle arrest. Furthermore, immunohistochemical staining showed decreased POX expression in tumor tissues. Importantly, HIF-1α signaling was impaired with POX expression due to the increased production of α-ketoglutarate, a critical substrate for prolyl hydroxylation and degradation of HIF-1α. Combined with previous in vitro findings and reported clinical genetic associations, these new findings lead us to propose POX as a mitochondrial tumor suppressor and a potential target for cancer therapy.